Monitoring Protein-Protein Interactions between the Mammalian Integral Membrane Transporters and PDZ-interacting Partners Using a Modified Split-ubiquitin Membrane Yeast Two-hybrid System
Serge M. Gisler(University of Zurich), Igor Štagljar(University of Toronto), Orson W. Moe(Io Therapeutics (United States)), Daniel G. Fuster(University of Bern), Tamara Radanovic, Mia Bertić(University of Toronto), Victoria Wong(University of Toronto), Randy A. Hall(Emory University), Daniel Markovich(The University of Queensland), Saranya Kittanakom, Juürg Biber, Heini Murer
Cited by 89
Related Papers
Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy
|The Lancet|2017|923
Hyperuricemia, Acute and Chronic Kidney Disease, Hypertension, and Cardiovascular Disease: Report of a Scientific Workshop Organized by the National Kidney Foundation
|American Journal of Kidney Diseases|2018|644
Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1
|New England Journal of Medicine|2021|509
Renal Transport of Uric Acid: Evolving Concepts and Uncertainties
|Advances in Chronic Kidney Disease|2012|394
Pathophysiologic basis for normouricosuric uric acid nephrolithiasis
|Kidney International|2002|346